CORC  > 中国医学科学院 北京协和医学院
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy
Wang, Xiao-Bing; Jiang, Xing-Ran; Yu, Xi-Ying; Wang, Lin; He, Shun; Feng, Fei-Yue; Guo, Li-Ping; Jiang, Wei; Lu, Shih-Hsin
2014
卷号105期号:2页码:176-185
关键词Diagnosis esophageal squamous cell carcinoma macrophage inhibitory factor 1 prognosis target
ISSN号1349-7006
DOI10.1111/cas.12331
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6682528
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Wang, Xiao-Bing,Jiang, Xing-Ran,Yu, Xi-Ying,et al. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy[J],2014,105(2):176-185.
APA Wang, Xiao-Bing.,Jiang, Xing-Ran.,Yu, Xi-Ying.,Wang, Lin.,He, Shun.,...&Lu, Shih-Hsin.(2014).Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.,105(2),176-185.
MLA Wang, Xiao-Bing,et al."Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy".105.2(2014):176-185.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace